Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02916966 · ClinicalTrials.gov registry record
Environmental Exposure and Neurological Diseases Questionnaire
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 460
- Enrollment target
NCT02916966 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 460 participants.
The verdict
NCT02916966 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 460 participants
- Enrollment target
Study Summary
The proposed research is particularly relevant to the National ALS Registry and public environmental health issues because it addresses the potential environmental causes of sporadic ALS. The research will develop an ALS surveillance program in Ohio that can be compared with the national and State-Metro Surveillance Programs of the National ALS Registry, and novel methodologies to determine the role of the cyanobacterial toxin, BMAA (beta-methylamino-L-alanine), and other environmental toxins/toxicants as risk factors for ALS. This work will advance the mission of the Centers for Disease Control Agency for Toxic Substances and Disease Registry (CDC ATSDR) National ALS Registry by offering data on ALS cases in Ohio that address public health concerns over the effects of chronic exposure to cyanobacterial blooms in Lake Erie.
Interventions
- OTHER Patient Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2016-10 |
| Est. Completion | 2023-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02916966
The ClinicalTrials.gov registry entry for NCT02916966 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient Registry is the first listed.
NCT02916966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02916966 about?
NCT02916966 is a clinical study titled "Environmental Exposure and Neurological Diseases Questionnaire". The proposed research is particularly relevant to the National ALS Registry and public environmental health issues because it addresses the potential environmental causes of sporadic ALS. The research will develop an ALS surveillance program in Ohio that can be compared with the national and State-M...
What is the current status of trial NCT02916966?
This trial is currently completed. The enrollment target is 460 participants. The study started on 2016-10. Estimated completion is 2023-09.
What interventions are being tested in trial NCT02916966?
The interventions under investigation include: Patient Registry (OTHER).
Who is sponsoring clinical trial NCT02916966?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.